It is shown that intracellular pAg accumulation can modulate binding of Vγ9Vδ2+ TCR in a BTN3A1-dependent manner, indicating the important role of TCR binding to BTN3A1 in pAg recognition.
Abstract
Phosphoantigen (pAg) recognition by Vγ9Vδ2+ T cells plays a critical role in immunity to pathogens and cancer. The butyrophilin (BTN) family of molecules have emerged as key regulators of γδ T cells; however, the underlying mechanisms remain unclear. Here, we demonstrate an interaction between BTN3A1 and Vγ9Vδ2+ T cell receptor (TCR) in a cell-free assay, confirming that BTN3A1 is a direct ligand for the Vγ9Vδ2+ TCR. Furthermore, immobilized recombinant BTN2A1 plus BTN3A1 extracellular domains are sufficient to activate Vδ2+ T cells. Finally, we show that intracellular pAg accumulation can modulate binding of Vγ9Vδ2+ TCR in a BTN3A1-dependent manner, indicating the important role of TCR binding to BTN3A1 in pAg recognition. These data confirm that BTN3A1, in conjunction with BTN2A1, is a direct ligand for Vγ9Vδ2+ TCR, providing the key interactions required for pAg recognition.
The findings reveal a dimerization-driven activation mechanism, inform the design of rigid TCR-crosslinking agonists, and suggest multivalency-induced clustering as a general paradigm for γδ TCR activation.
Ze-Zhi Li, Yi-Hua Fan, Jing Li et al.· bioRxiv· 0 citations
The activation of Vγ9Vδ2 T cells has emerged as a promising modality in cancer immunotherapy. Phosphate and phosphonate prodrugs of Vγ9Vδ2 T cell phosphoantigens have been developed as potent activators of Vγ9Vδ2 T cells that are capable of effectively facilitating lysis of a range of cancer cells in vitro. In this wor...
M. Sharif, C. M. A. Pinna, K. Rakhimova et al.· ACS Pharmacology & Translati...· 0 citations
This study presents the discovery and first functional characterization of chicken lipid‐reactive Natural Killer T (NKT)‐like cells, resolving a long‐standing knowledge gap in avian immunology. Using purified TCRVβ2+ lymphocytes, we demonstrate through rigorous experiments combining shRNA‐mediated gene silencing, pharm...
Nitin Kamble, Faisal R. Anjum, S. Behboudi· European Journal of Immunolo...· 0 citations
Introduction CD19 is a key B-cell co-receptor that amplifies B-cell receptor (BCR) signaling and tunes B-cell activation thresholds. How the conformation of the CD19 cytoplasmic domain is regulated to restrain basal and BCR-induced signaling remains incompletely understood. We investigated whether the phosphoinositide...
Bastien Möes, Alice Mostafa, R. Malempré et al.· Frontiers in Immunology· 0 citations
Integrin α3β1 (ITGα3β1) is a member of an integrin subfamily that binds to laminin proteins and promotes attachment of epithelial cells to the basement membrane. ITGα3β1 forms a complex with the tetraspanin CD151, and loss-of-function mutations in both ITGα3 and CD151 cause epidermolysis bullosa, a severe skin blisteri...
L. Litzau, Elizabeth K. Wren, Andrew C. Kruse et al.· bioRxiv· 0 citations
C5-Fc# is established as a rationally engineered dual-specificity inhibitor with translational potential for autoimmune diseases after disrupting NK- and T-cell conjugate formation and reducing CD244- and CD2-dependent cytotoxicity.
Olga Bautista-Cerecero, P. Hernández-Luis, Pablo Martínez-Vicente et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
